| Literature DB >> 25671169 |
Anna Maria Pappa1, Varvara Karagkiozaki1, Silke Krol2, Spyros Kassavetis3, Dimitris Konstantinou1, Charalampos Pitsalidis1, Lazaros Tzounis1, Nikos Pliatsikas3, Stergios Logothetidis1.
Abstract
Electrospun nanofibrous scaffolds have been extensively used in several biomedical applications for tissue engineering due to their morphological resemblance to the extracellular matrix (ECM). Especially, there is a need for the cardiovascular implants to exhibit a nanostructured surface that mimics the native endothelium in order to promote endothelialization and to reduce the complications of thrombosis and implant failure. Thus, we herein fabricated poly-ε-caprolactone (PCL) electrospun nanofibrous scaffolds, to serve as coatings for cardiovascular implants and guide tissue regeneration. Oxygen plasma treatment was applied in order to modify the surface chemistry of the scaffold and its effect on cell attachment and growth was evaluated. The conditions of the surface modification were properly adjusted in order to define those conditions of the treatment that result in surfaces favorable for cell growth, while maintaining morphological integrity and mechanical behavior. Goniometry (contact angle measurements), scanning electron microscopy (SEM), atomic force microscopy (AFM), and X-ray photoelectron spectroscopy (XPS) measurements were used to evaluate the morphological and chemical changes induced by the plasma treatment. Moreover, depth-sensing nanoindentation was performed to study the resistance of the plasma-treated scaffolds to plastic deformation. Lastly, the cell studies indicated that all scaffolds were cytocompatible, with the plasma-treated ones expressing a more pronounced cell viability and adhesion. All the above findings demonstrate the great potential of these biomimetic tissue-engineering constructs as efficient coatings for enhanced compatibility of cardiovascular implants.Entities:
Keywords: cardiovascular implants; electrospun nanofibers; plasma treatment; scaffold; tissue engineering
Year: 2015 PMID: 25671169 PMCID: PMC4311659 DOI: 10.3762/bjnano.6.24
Source DB: PubMed Journal: Beilstein J Nanotechnol ISSN: 2190-4286 Impact factor: 3.649
Figure 1SEM and AFM images of the (a,d) untreated PCL electrospun scaffolds and of the O2-plasma modified ones, with (b,e) P = 20 W and (c,f) P = 40 W (the axis in AFM images is in μm).
Surface characteristics from AFM analysis and water contact angle measurements for the untreated and the O2-plasma-treated nanofibrous scaffolds.
| PCL scaffold | roughness, | peak-to-valley, | contact angle (degrees) |
| untreated | 200.48 | 225.59 | 91.3 |
| O2, 20 W | 245.25 | 287.22 | 21.4 |
| O2, 40 W | 89.5 | 118.73 | 19.8 |
Figure 2XPS spectra of the untreated PCL electrospun scaffolds and the O2-plasma modified ones, with P = 20 W and P = 40 W.
Surface atomic composition (atom %) and concentration of the different chemical bonds (%) on the untreated and the O2-plasma-treated nanofibrous scaffolds.
| % | untreated | O2, 20 W | O2, 40 W |
| C 1s | 70.89 | 69.97 | 69.91 |
| O 1s | 29.11 | 30.03 | 30.29 |
| C–C (285.0 eV) | 44.2 | 44.8 | 13.0 |
| C–O (286.5 eV) | 35.0 | 33.8 | 22.2 |
| C=O (288.9 eV) | 20.8 | 21.4 | 48.5 |
Figure 3The elastic modulus values of the untreated PCL electrospun scaffolds and the plasma-modified ones (20 W) versus the contact depth. Every curve comes from a nanoindentation measurement to a different surface location of the samples.
Figure 4(a,b) MTT assay of L929 cells in direct contact with the examined systems after 1, 3 and 7 days, in terms of optical density values as well as the normalized % cell viability, respectively, and (c) optical imaging of the cell morphology in the predetermined time periods for the untreated and the plasma treated scaffolds.
Figure 5SEM micrographs of the (a–c) untreated PCL electrospun scaffolds for 1,3 and 7 days of direct contact with cells and (d–f) and of the O2-plasma-modified scaffolds, at the predetermined time periods.